Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
18 avr. 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...